Pomerantz says Park Ha investors face Sept. 28 deadline for lead-plaintiff bid
Pomerantz LLP says investors in Park Ha Biological Technology Co., Ltd. have until Sept. 28, 2026, to seek lead-plaintiff appointment in a class action tied to alleged stock manipulation.
Pomerantz LLP says investors in Park Ha Biological Technology Co., Ltd. have until Sept. 28, 2026, to seek lead-plaintiff appointment in a class action tied to alleged stock manipulation.
Pomerantz said in an Aug. 27, 2026, investor alert that a securities class action has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) and certain officers and/or directors. The notice says the case concerns whether the company engaged in securities fraud or other unlawful business practices.
The law firm said the complaint alleges a pump-and-dump and market-manipulation scheme that relied on social-media misinformation and people allegedly posing as financial professionals. The notice says Park Ha’s stock rose from its $4.00 initial public offering price to an all-time high of $41.49 on July 7, 2025.
Pomerantz said the complaint alleges that the spike was not supported by material corporate developments or legitimate business prospects. The notice also says public reports and investigations showed the stock was used in a promotional scheme, with impersonators appearing in online forums, chat groups and social media posts.
Pomerantz said investors who purchased or otherwise acquired Park Ha securities during the class period have until Sept. 28, 2026, to ask the court to appoint them as lead plaintiff. Lead-plaintiff status can affect how the case proceeds.
According to the notice, investors with losses can contact Danielle Peyton at [email protected], 646-581-9980, or toll-free 888.4-POMLAW ext. 7980. Email inquiries should include a mailing address, telephone number and the number of shares purchased.
Pomerantz said a copy of the complaint is available on its website. The firm described itself as having offices in New York, Chicago, Los Angeles, London, Paris and Tel Aviv, and said it was founded by the late Abraham L. Pomerantz and has operated for more than 85 years.
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Sources
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.